RDH10 Antibodies

Santa Cruz Biotechnology features a diverse variety of RDH10 monoclonal antibodies for investigating RDH10 in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RDH10, or retinol dehydrogenase 10, is a crucial enzyme involved in the metabolism of retinoids, which are essential for vision, cellular differentiation, and embryonic development. By converting retinol to retinal, RDH10 plays a significant role in the visual cycle and is vital for maintaining proper retinal function. Research has shown that RDH10 expression levels vary across different tissue types, with particularly high expression in the retinal pigment epithelium. Understanding RDH10 function has become increasingly important as studies reveal its involvement in embryonic development and organ formation. Dysregulation of RDH10 has been linked to various pathological conditions, highlighting its significance in human health. Current research continues to uncover new aspects of RDH10 biology and its potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of RDH10's role in development, vision, and disease processes.